ICMR denies details of Covaxin funding sought under RTI Act

May 08, 2021 03:32 am | Updated 03:32 am IST - NEW DELHI

The Indian Council of Medical Research (ICMR) has refused to share a copy of its MoU with Bharat Biotech, and the amount spent on the development of Covaxin sought by a Right to Information application filed by the Software Freedom Law Centre, India (SFLC.in).

ICMR has, however, disclosed that the royalty received by it from the sale of Covaxin would be 5% on its net sales.

The not-for-profit SFLC.in has said that since the ICMR qualifies to be a “public authority” under the Section 2(h) of the Right to Information Act, 2005, it had filed an application seeking a copy of the memorandum of understanding, funding details, and the royalty earned by the ICMR on Covaxin sales.

ICMR has responded that the copy of the MoU and the amount spent on the development of the vaccine is “third party confidential information” under Section 8(1)(j).

Prasanth Sugathan, legal director, SFLC, India, said, “ICMR being a government entity should have proactively disclosed the information regarding the MoU with Bharat Biotech. In the current scenario, it is unacceptable that the ICMR chooses to keep information relating to the MoU and the funding details under a veil of secrecy.”

He added that the ICMR should be transparent and take steps to ensure that the public gets the benefit of the research funded by public money by transferring the technology to other manufacturers including public sector units.

SFLC.in in a statement said it has filed a first appeal with the First Appellate Authority at the ICMR.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.